Trends in US approvals: new biopharmaceuticals and vaccines
暂无分享，去创建一个
[1] S. Iwanicki. The Public Health Security and Bioterrorism Preparedness and Response Act of 2002 , 2007 .
[2] Melissa R. Leuenberger-Fisher. The Road to Follow on Biologics: Are We There Yet? , 2004 .
[3] J M Reichert,et al. New biopharmaceuticals in the USA: trends in development and marketing approvals 1995-1999. , 2000, Trends in biotechnology.
[4] M. Manocchia,et al. The First Biopharmaceuticals Approved in the United States: 1980-1994 , 1996 .
[5] D. Dudzinski. Reflections on historical, scientific, and legal issues relevant to designing approval pathways for generic versions of recombinant protein-based therapeutics and monoclonal antibodies. , 2005, Food and drug law journal.
[6] Innovation OR Stagnation. Challenge and Opportunity on the Critical Path to New Medical Products , 2004 .
[7] Weeks Ea,et al. Is it worth the trouble? The new policy on dissemination of information on off-label drug use under the Food and Drug Administration Modernization Act of 1997. , 1999 .